Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02756923 · ClinicalTrials.gov registry record

Regulation of Stem Spermatogonia in the Mature Testis

A clinical trial, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
142
Enrollment target

NCT02756923 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 142 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02756923 has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
142 participants
Enrollment target

Study Summary

Investigative trial to evaluate the role of a glial cell lined derived neurotrophic factor (GDNF) in regulation of spermatogonial renewal and testicular function. Goal of the trial is to provide greater information on the mechanisms that effect stem spermatogonial maintenance renewal and proliferation in its relation to male infertility.

Trial Details

FieldValue
Enrollment Target 142 participants
Start Date 2012-04
Est. Completion 2019-12-05

What the Registry Record Tells You About NCT02756923

The ClinicalTrials.gov registry entry for NCT02756923 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02756923 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02756923 about?

NCT02756923 is a clinical study titled "Regulation of Stem Spermatogonia in the Mature Testis". Investigative trial to evaluate the role of a glial cell lined derived neurotrophic factor (GDNF) in regulation of spermatogonial renewal and testicular function. Goal of the trial is to provide greater information on the mechanisms that effect stem spermatogonial maintenance renewal and proliferati...

What is the current status of trial NCT02756923?

This trial is currently completed. The enrollment target is 142 participants. The study started on 2012-04. Estimated completion is 2019-12-05.

Who is sponsoring clinical trial NCT02756923?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.